Rallybio Corporation
RLYB
$0.67
$0.023.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.02M | -9.70M | -9.44M | -11.04M | -11.47M |
| Total Depreciation and Amortization | 35.00K | 26.00K | 28.00K | 30.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.42M | 1.75M | 2.26M | 2.08M | 2.32M |
| Change in Net Operating Assets | -1.19M | -450.00K | -3.05M | -925.00K | -4.43M |
| Cash from Operations | -6.55M | -8.38M | -10.21M | -9.86M | -13.55M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.23M | 3.04M | 11.08M | -1.57M | 22.21M |
| Cash from Investing | 29.23M | 3.04M | 11.08M | -1.57M | 22.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 10.00K | -- | 18.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -11.00K |
| Cash from Financing | 0.00 | 10.00K | -- | 18.00K | -11.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.68M | -5.33M | 876.00K | -11.42M | 8.65M |